Inhibition of interleukin-1ß reduces myelofibrosis and osteosclerosis in mice with JAK2-V617F driven myeloproliferative neoplasm. (2022)
Attributed to:
Joint Wellcome and MRC Centre, ‘Wellcome Trust – Medical Research Council Cambridge Stem Cell Institute’
funded by
MRC
Abstract
No abstract provided
Bibliographic Information
Digital Object Identifier: http://dx.doi.org/10.1038/s41467-022-32927-4
PubMed Identifier: 36100613
Publication URI: http://europepmc.org/abstract/MED/36100613
Type: Journal Article/Review
Volume: 13
Parent Publication: Nature communications
Issue: 1
ISSN: 2041-1723